PT Central Proteina Prima Tbk EBIT

The latest EBIT for CPRO.JK is $720B as of June 2026. That compares with $760B in the prior-year period — down 5.8% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside PT Central Proteina Prima Tbk's historical trend and sector peers before judging valuation or financial health.

Over the past year, CPRO.JK's EBIT moved from $760B to $720B — a 5.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PT Central Proteina Prima Tbk's operating scale or balance-sheet position.

Against its sector companies, CPRO.JK currently prints $720B for EBIT, while the sector average sits near $2.6T. That is roughly 71.9% below the sector mean. Large gaps often invite a closer look at PT Central Proteina Prima Tbk's growth, margins, and balance sheet.

A EBIT figure of $720B for CPRO.JK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting CPRO.JK's EBIT ($720B), review year-over-year change from $760B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.